Skip to content Skip to sidebar Skip to footer

5 ASX Healthcare Companies with Game Changing Milestones in 2026!

2026 is set to be a big year for several ASX Healthcare Companies, especially companies in the pre-commercialisation stage. The two keys to get drugs or devices to market are…

ByNick Sundich

Sep 2025

Healthcare Stocks Life Sciences Penny Stocks Small Caps Stocks

Actinogen Medical (ASX:ACW): Will history repeat itself? Can it bounce back from a troublesome Phase 2 trial?

Actinogen Medical (ASX:ACW) is the poster child for how volatile biotech stocks can be. the last time we wrote about this company was in August last year when shares more…

ByNick Sundich

Aug 2025

Healthcare Stocks Life Sciences

Here are 5 ASX biotechs expecting clinical trial results in the next few months!

Here are 5 ASX biotechs expecting clinical trial results in the next few months! Dimerix (ASX:DXB) Dimerix is in the middle of a Phase III trial or its DMX-200 drug…

ByNick Sundich

Aug 2025

Education

Here’s how to use stop losses to help you minimise investment losses and protect your gains

A stop loss is one of the best ways for investors to minimise losses on any investment. It is a pre-determined price at which investors will sell out of a company…

ByNick Sundich

Sep 2024

Healthcare Stocks Mid Cap Stocks News Penny Stocks Small Caps Stocks

The 2024 Pitt Street Research Life Sciences Conference is coming up! And you’re invited!

The Pitt Street Research Life Sciences Conference is happening on September 19, 2024! The Life Sciences sector in Australia and New Zealand continues to mature in 2024. In spite…

ByNick Sundich

Apr 2024

Uncategorized

5 ASX Health stocks to add to your porfolio

5 ASX Health Stocks Stuart Roberts from Stocks Down Under discussed the potential promise of biotech, sharing his perspectives about the industry's future amidst changing interest rates. He compares the…

ByMarc Kennis

Sep 2022

Life Sciences

Actinogen Medical (ASX: ACW): Good news on phase 2 trials can catapult this stock

Working on a new drug for Alzheimer’s disease Actinogen Medical (ASX: ACW) is a Sydney-based biotechnology company working on finding treatments for Alzheimer’s and other neurological diseases. It’s…

ByMarc Kennis

the Kick-ass Multipurpose WordPress Theme

5 ASX Healthcare Companies with Game Changing Milestones in 2026!

Actinogen Medical (ASX:ACW): Will history repeat itself? Can it bounce back from a troublesome Phase 2 trial?

Here are 5 ASX biotechs expecting clinical trial results in the next few months!

Here’s how to use stop losses to help you minimise investment losses and protect your gains

The 2024 Pitt Street Research Life Sciences Conference is coming up! And you’re invited!

5 ASX Health stocks to add to your porfolio

Actinogen Medical (ASX: ACW): Good news on phase 2 trials can catapult this stock

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Add Your Heading Text Here